Why This Diabetes Stock Could Sprint In 2020 On Medtronic's Setback

ALLISON GATLIN
Why This Diabetes Stock Could Sprint In 2020 On Medtronic's Setback

Tandem Diabetes is poised to outperform bearish quarterly expectations, an analyst said as he predicted Tandem Diabetes stock would continue a sizable run in 2020 and take share from rivals.